To strengthen the clinical evidence supporting the aforementioned results, we performed an immunofluorescence (IF) assay to investigate the correlation between ATP6V0A1 and RABGEF1, TGF-β1, or memory CD8+ T-cell effectiveness on the paraffin-embedded tumor sections obtained from 32 CRC patients. The gene discussed is RABGEF1; the disease is colorectal carcinoma.